Literature DB >> 23669020

HLA-B*58:01 strongly associates with allopurinol-induced adverse drug reactions in a Japanese sample population.

Hiroyuki Niihara, Sakae Kaneko, Takahumi Ito, Takashi Sugamori, Nobuyuki Takahashi, Kunie Kohno, Eishin Morita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23669020     DOI： 10.1016/j.jdermsci.2013.04.013

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  10 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 2.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

Review 3.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

Review 4.  Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.

Authors:  Ran Wu; Yi-Ju Cheng; Li-Li Zhu; Lei Yu; Xue-Ke Zhao; Min Jia; Chang-Hui Wen; Xing-Zhen Long; Ting Tang; Ai-Juan He; Yi-Yan Zeng; Zun-Feng Ma; Zhi Zheng; Mu-Zi Ni; Gong-Jing Cai
Journal:  Oncotarget       Date:  2016-12-06

Review 5.  Adverse Immunologically Mediated Oral Mucosal Reactions to Systemic Medication: Lichenoid Tissue Reaction/Interface Dermatitis-Stomatitis, Autoimmune Vesiculobullous Disease, and IgE-Dependent and Immune Complex Reactions.

Authors:  R A G Khammissa; R Chandran; A Masilana; J Lemmer; L Feller
Journal:  J Immunol Res       Date:  2018-06-10       Impact factor: 4.818

Review 6.  Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Akito Hasegawa; Riichiro Abe
Journal:  F1000Res       Date:  2020-06-16

7.  Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report.

Authors:  Wei Zuo; Li-Ping Wen; Jun Li; Dan Mei; Qiang Fu; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

8.  Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes.

Authors:  Kye Hwa Lee; Dong Yoon Kang; Hyun Hwa Kim; Yi Jun Kim; Hyo Jung Kim; Ju Han Kim; Eun Young Song; James Yun; Hye-Ryun Kang
Journal:  Clin Transl Allergy       Date:  2022-01-14       Impact factor: 5.871

Review 9.  Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.

Authors:  Therdpong Tempark; Shobana John; Pawinee Rerknimitr; Patompong Satapornpong; Chonlaphat Sukasem
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 10.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.